Clinical

Dataset Information

0

Dolcanatide in Preventing Colorectal Cancer in Healthy Volunteers


ABSTRACT: This phase I trial studies how well dolcanatide works in preventing colorectal cancer in healthy participants. Dolcanatide is similar to a natural hormone released into the intestine. It is thought that people who have low levels of the hormone are more likely to get colon cancer. It may be possible to prevent colon cancer by giving a drug that is similar to the hormone, such as dolcanatide.

DISEASE(S): Colorectal Carcinoma,Colorectal Neoplasms

PROVIDER: 2255697 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2152210 | ecrin-mdr-crc
2022-08-25 | ST002282 | MetabolomicsWorkbench
2014-08-11 | E-GEOD-31413 | biostudies-arrayexpress
2011-12-07 | GSE28907 | GEO
2021-11-10 | GSE179130 | GEO
2018-01-27 | GSE109694 | GEO
2013-05-23 | E-GEOD-47196 | biostudies-arrayexpress
2013-05-23 | GSE47196 | GEO
| S-EPMC3672386 | biostudies-literature
2019-04-03 | E-MTAB-7055 | biostudies-arrayexpress